DNDN - Dendreon Corp. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
DNDN - Dendreon Corp.

An SI Board Since June 2000

Posts	SubjectMarks	Bans	Symbol
751	79	0	DNDN

Emcee: brk	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
701	Form 8-K for DENDREON CORP 13-Jan-2011 Other Events, Financial Statements and	tnsaf	-	1/14/2011
700	my end of year review of DNDN INTRO Here's my semi-annual exercise to see i	tktrimbath	1	12/31/2010
699	finance.yahoo.com IMO--This is going to erode any potential that DNDN has when	Arthur Radley	-	9/25/2010
698	JNJ’s phase-3 Abiraterone trial succeeds in HRPC: siliconinvestor.com	DewDiligence_on_SI	1	9/9/2010
697	www.dendreon-opinion.com is a new website/blog dedicated to reporting opinions o	Richard Chowning	-	8/24/2010
696	Dendreon gets a FDA warning about its promotional materials: fda.gov Obviously	tuck	-	8/6/2010
695	It's the only "news" today, and the stock is again weak, so it wou	tuck	2	7/7/2010
694	Did anyone think a NICE-like agency <i>would</i> cover Provenge?	DewDiligence_on_SI	-	7/7/2010
693	Now a different physician analyst at seekingalpha runs cost/benefit numbers for	tuck	-	7/7/2010
692	Incidentally, rkrw is right, as usual, about the author's representation of	tuck	-	7/2/2010
691	"Wee"? Darn! From your post on the firesale thread (or maybe here?),	scaram(o)uche	-	7/2/2010
690	Better credentials than most on seeking alpha is what I meant. Didn't say h	tuck	-	7/2/2010
689	>> better credentials than most << (deleted)	scaram(o)uche	-	7/2/2010
688	FWIW I believe he represents a Provenge competitor, Bavarian Nordic. Does some s	rkrw	-	7/2/2010
687	No downgrades today, but an opposing view from a Seekingalpha author (better cre	tuck	-	7/2/2010
686	Did you see the NCD initiated at CMS? Has taken the stock into the high $20s.	tuck	-	7/1/2010
685	my mid year review of DNDN INTRO Here's my semi-annual exercise to see if I	tktrimbath	-	6/30/2010
684	Provenge Poised for Broad Insurance Coverage, Despite Grumbles on Price The Pink	Arthur Radley	-	6/2/2010
683	I've noticed that Dew Diligence has been rather quiet since last year. I wo	Hawkmoon	1	5/2/2010
682	There are many estimates, and great controversy amongst some of the various prop	tktrimbath	-	4/30/2010
681	Thanks for your reply. Is there a good estimate as to how this FDA approval may	George8	-	4/30/2010
680	Check back in my ASM posts, but as I recall, the same technology may work agains	tktrimbath	-	4/30/2010
679	I wonder what Provenge could possibly do to other forms of cancer? Of course, h	George8	-	4/30/2010
678	Congrats to longs. Provenge approved. Cheers, Tuck	tuck	-	4/29/2010
677	2. New Provenge data confirms 3-year survival benefit By John Carroll Comment	mlkr	-	3/4/2010

Go to reply# or date (mm/dd/yy):